Ann: OPMD Orphan Disease Program Update, page-5

I'm sorry Blane but it won't "run a little'. It will RACE LIKE THE WIND as the company becomes increasingly recognised in North America and Europe by the greater biotechnology industry instead of being an all-but forgotton, never has-been Australian biotech basket case. If it ran 26% on the ASX today it will definitely settle at 70 or 80 % on the Nasdaq tonight if not higher after hitting intra-day highs of 100-150%. Shame on Australian investors who are trapped in an echo chamber where the dominant voices reflect the vested interests of a few fund managers who will not look beyond the miners or banks. SHAME SHAME SHAME!